Parabilis Medicines Earnings
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
27.48-0.61 (-2.17%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Parabilis Medicines earnings summary
In its most recent report on Aug 13, 2026 (Q2 2026), PBLS posted EPS of $-2.32. Revenue for the quarter was $148,000.
Summary generated from market data by MetaCap's automated system. Methodology
PBLS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $-2.32 | — | +6.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.